Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: Merck KGaA, Darmstadt, Germany
Condition: Squamous Cell Carcinoma of the Head and Neck
NCT00971932
Study of Cetuximab in Combination With Chemotherapy in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.